The treatment of severe malaria.

In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Dondorp, A, Day, N
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2007

Samankaltaisia teoksia